FRIENDSWOOD, Texas, July 9, 2026 /PRNewswire/ — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter ended June 30, 2026, after the close of…
Source: prnewswire
Country: United States